This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Mar 15;64(6):794-795.

doi: 10.1093/cid/ciw858.

Herpes Zoster Vaccine and the Medicare Population

Affiliations

PMID: 28362956
DOI: 10.1093/cid/ciw858

Editorial

Herpes Zoster Vaccine and the Medicare Population

Steven Black. Clin Infect Dis. 2017.

. 2017 Mar 15;64(6):794-795.

doi: 10.1093/cid/ciw858.

Author

Affiliation

¹ Center for Global Health, Cincinnati Children's Hospital, Ohio, USA.

PMID: 28362956
DOI: 10.1093/cid/ciw858

No abstract available

Keywords: Medicare; aging populations.; herpes; vaccines.

PubMed Disclaimer

Comment on

Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
Izurieta HS, Wernecke M, Kelman J, Wong S, Forshee R, Pratt D, Lu Y, Sun Q, Jankosky C, Krause P, Worrall C, MaCurdy T, Harpaz R. Izurieta HS, et al. Clin Infect Dis. 2017 Mar 15;64(6):785-793. doi: 10.1093/cid/ciw854. Clin Infect Dis. 2017. PMID: 28362955

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information